` Comparison: AKRO vs VRTX - Alpha Spread

AKRO
vs
VRTX

Over the past 12 months, AKRO has outperformed VRTX, delivering a return of +5% compared to the VRTX's 3% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
AKRO
VRTX
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

AKRO Intrinsic Value
HIDDEN
Show
VRTX Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Akero Therapeutics Inc
NASDAQ:AKRO
54.65 USD
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
467.805 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
AKRO, VRTX

AKRO
VRTX
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Akero Therapeutics Inc
Revenue
Vertex Pharmaceuticals Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
AKRO, VRTX

AKRO
VRTX
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Akero Therapeutics Inc
NASDAQ:AKRO
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

AKRO
0%
VRTX
86.2%

Operating Margin

AKRO
0%
VRTX
39%

Net Margin

AKRO
0%
VRTX
32.9%

FCF Margin

AKRO
0%
VRTX
27.8%

ROE

AKRO
-34.5%
VRTX
22.5%

ROA

AKRO
-32.1%
VRTX
16.4%

ROIC

AKRO
-204.7%
VRTX
25.2%

ROCE

AKRO
-38.1%
VRTX
23%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
AKRO, VRTX

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
AKRO, VRTX

Performance Gap Between AKRO and VRTX
HIDDEN
Show

Performance By Year
AKRO, VRTX

Loading
AKRO
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare AKRO to other stocks
PNEXF
Pharnext SCA
ABBV
Abbvie Inc
AMGN
Amgen Inc
GILD
Gilead Sciences Inc
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account